At Oticon, innovation is Real. On February 23rd, the company launched its new Oticon Real™ miniRITE and miniBTE hearing aids, powered by the new Polaris R™ chip platform. Oticon Real, which picks up from where Oticon More™ left off,  is designed to give hearing aid users a full spectrum of sounds in different environments while protecting against sudden disruptive signals and wind noise.

But there’s quite a bit more to the story. HearingTracker thought it would be a good idea to get an insider’s viewpoint about the new hearing aids. So, we turned to Oticon’s U.S. President Gary Rosenblum.

Rosenblum has been at the helm of Oticon U.S. since October 2016 and has quickly become an industry leader, lending his unique experiences and knowledge about general healthcare in presentations, seminars, articles, and serving as the current Chairman of the Hearing Industries Association (HIA).  Before joining Oticon, he led various commercial functions for Johnson & Johnson, including channel development for J&J’s Diabetes Care franchise. Gary holds an MBA in Marketing & Business Strategy from Cornell and earned his undergraduate degree from Washington University in St Louis.

We caught up with him at his office at Oticon headquarters in Somerset, NJ.

HearingTracker: Hi Gary, thanks for your time this morning. I know you're very busy with the new product launch.

Rosenblum: Thanks Karl. It’s always a pleasure, and it’s an exciting time for Oticon.

HearingTracker: Oticon More, which was released only 2 years ago, has been a very successful hearing aid. Now, on More’s heels comes its successor, Oticon Real. Can you tell us what excites you most about this new product?

Rosenblum: Well, actually, I think you’ve alluded to a big part of my answer. Because, in truth, Oticon Real builds upon all of our previous technology, going back more than 10 years ago to when Oticon introduced the BrainHearing™ concept to the industry. Soon after introducing BrainHearing, Oticon launched Oticon Opn™, the inflection point where we moved away from traditional directionality and focused on the open soundscape and 360-degree hearing. From there, we introduced Opn S™ [in 2019] on the Velox S™ platform, which used our OpenSound Optimizer™ to increase speech-in-noise capabilities and sound quality while significantly reducing feedback.

Of course, there’s a lot more to Oticon Real than that, but what I’d emphasize is that it’s built on industry-leading, extraordinary technology. In terms of sound quality and hearing-in-noise capabilities, I believe the Opn and Opn S technology we introduced 4-7 years ago can still go head-to-head with the best hearing aids on the market today. Every time Oticon launches a product, we make sure that 8 out of 10 patients believe it’s a marked improvement over our existing technology. So, we’ve added significant benefits with each product launch and we continue to do so with Oticon Real.

HearingTracker: Can you tell us more about the new Polaris R platform that powers Oticon Real?

Rosenblum: So, Karl, you know I’m a marketing guy [MBA in marketing from Cornell and previous leadership positions at Johnson & Johnson Diabetes Care, Abbott Labs and Pfizer]. That means I tend to think about products from the standpoint of: 1) What's the premise or key insight; 2) What’s the promise or key benefit, and 3) What's the proof or reasons to believe? So, for the premise and insights, there are about 7 out of 10 hearing aid users who are bothered by the annoying and disturbing sounds we’ve talked about throughout the day. And about 9 out of 10 hearing care professionals know this is true but have been working with hearing aids that don’t give them enough of a solution to resolve this problem to the satisfaction of the patient.

Is it a surprise that our competition is starting to go in that direction, too? No. Frankly, it is surprising that it has taken this long given how important this challenge is for people with hearing loss. But we have a big advantage in having a research facility at Eriksholm in Denmark dedicated to the cognitive science of hearing. And we have over a decade worth of technology to build from that is all based on the BrainHearing concept.

Ultimately, the proof is in the product. When you think about some of the important core attributes of a hearing aid, it often comes down to how well it performs in a noisy listening environment. It’s about how fatigued the user feels at the end of the day after trying to comprehend speech in challenging situations. It’s sound quality, listening clarity, and speech understanding, which has so much to do with brain hearing and the technology we’ve developed. It all boils down to overall experience, benefit, and value for the user.

What is the listening benefit you're experiencing as a patient? Have we solved your challenges? That's the real proof. This is where we are focused.

HearingTracker: Switching gears to the overall hearing aid market, I know you’ve always been a proponent of the medical model as the “gold standard” for hearing care. How do you see over-the-counter (OTC) hearing aids progressing and integrating with traditional hearing healthcare?

While we don’t believe OTC will revolutionize the industry, we believe it will broaden access to hearing health.  I’m hopeful that the hype about OTC ultimately convinces more people to get their hearing checked and address their hearing loss.  We want more people to be helped.  We still strongly believe that the best way to address hearing loss involves the hearing care professional.  We offer hearing aids in all different price ranges, so the user can get a normal hearing aid close to the price of some OTC devices.  Oticon’s Research & Development focus on creating life-changing technology will not change as we continue to develop our products based on the BrainHearing concept.  This view is very different from a very simple OTC device.

HearingTracker: Well, I think we’re out of time. Thanks for taking the time to talk with us, Gary. It’s always great to hear your perspectives and we look forward to learning more about Oticon Real.

Rosenblum: Thank you, Karl.

Reference

1. Rosenblum G, Beck DL. Over the counter hearing aids: Opinions and perspectives 2018. The Hearing Professional. 2018:35-55.